about
Prolonged prone positioning under VV-ECMO is safe and improves oxygenation and respiratory compliance.Review of heart failure treatment in type 2 diabetes patients: It's at least as effective as in non-diabetic patients!French Intensive Care Society, International congress - Réanimation 2016Assessment of Left Ventricular Ejection Fraction Calculation on Long-axis Views From Cardiac Magnetic Resonance Imaging in Patients With Acute Myocardial Infarction.Factors of negativity of electrophysiological study in children and teenagers complaining of tachycardia and prognostic significance.What is The Utility of Electrophysiological Study in Elderly Patients with Syncope and Heart Disease?AV nodal reentrant tachycardia or AV reentrant tachycardia using a concealed bypass tract-related adverse events.Electrophysiological study generally is negative in patients <40 years suspected of supraventricular tachycardia but also complaining of chest pain and/or syncope.Outcome of patients with septic shock and high-dose vasopressor therapyEffectiveness of a multidisciplinary heart failure disease management programme on 1-year mortality: Prospective cohort studyPeriatrial epicardial fat is associated with markers of endothelial dysfunction in patients with atrial fibrillationReproducibility in echocardiographic assessment of diastolic function in a population based study (the STANISLAS Cohort study)Risk and outcome after ablation of isthmus-dependent atrial flutter in elderly patients.Quantification of Treatment Effect Modification on Both an Additive and Multiplicative Scale.Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocPrediction of Left Ventricular Remodeling after a Myocardial Infarction: Role of Myocardial Deformation: A Systematic Review and Meta-AnalysisDesign of the DRAGET Study: a multicentre controlled diagnostic study to assess the detection of acute rejection in patients with heart transplant by means of T2 quantification with MRI in comparison to myocardial biopsies.Outcomes of patients admitted to intensive care units for acute manifestation of small-vessel vasculitis: a multicenter, retrospective studyManagement of suspected acute heart failure dyspnea in the emergency department: results from the French prospective multicenter DeFSSICA survey.Diagnostic performance of peroxiredoxin 1 to determine time-of-onset of acute cerebral infarction.Cardiac remodeling following reperfused acute myocardial infarction is linked to the concomitant evolution of vascular function as assessed by cardiovascular magnetic resonanceRight isovolumic contraction velocity predicts survival in pulmonary hypertension.Association between orthostatic hypotension and cardiovascular risk, cerebrovascular risk, cognitive decline and falls as well as overall mortality: a systematic review and meta-analysis.Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: resultAntithrombotic therapy in heart failure patients with and without atrial fibrillation: update and future challenges.Influence of advancing age on clinical presentation, treatment efficacy and safety, and long-term outcome of pre-excitation syndromes: a retrospective cohort study of 961 patients included over a 25-year period.Serum Chloride and Sodium Interplay in Patients With Acute Myocardial Infarction and Heart Failure With Reduced Ejection Fraction: An Analysis From the High-Risk Myocardial Infarction Database Initiative.Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial.Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity: Insight from the EMPHASIS-HF trial.Moderate Hypothermia Improves Cardiac and Vascular Function in a Pig Model of Ischemic Cardiogenic Shock Treated With Veno-Arterial ECMO.Age-related location of manifest accessory pathway and clinical consequences.Coronary angiography in worsening heart failure: determinants, findings and prognostic implications.Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF.Development of a mobile phone-based intervention to improve adherence to secondary prevention of coronary heart disease in China.Predictors and prognostic significance of tachycardiomyopathy: insights from a cohort of 1269 patients undergoing atrial flutter ablation.Aorta calcification burden: Towards an integrative predictor of cardiac outcome after transcatheter aortic valve implantation.Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect.Association of various blood pressure variables and vascular phenotypes with coronary, stroke and renal deaths: Potential implications for prevention.Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort.Cumulative Effects of Several Target Organ Damages in Risk Assessment in Hypertension.
P50
Q27320815-DC499488-C314-43A0-9DEE-FB0BCD90E8D6Q28084010-6CB388B0-30A1-4237-804C-794C9EAAE4C2Q28550357-0FAAE05E-02BA-4C93-AC7B-6F1026EBA29AQ30375857-BE77F361-D723-4CFE-A6F2-E150BDFC12DEQ33164557-D416BEE3-B9DE-49EE-95EE-22CAB8BAB335Q33165581-E28E044A-5BFF-4E2A-86B3-8A9C41C39D08Q33166027-B085CC69-FE1D-4684-9D53-5B542A594709Q33166538-8D194E87-5A0F-4E94-9B4A-8A2462409C50Q33580796-6B0A14AB-D9BA-4217-8A1D-871F09C9839FQ33595106-B257F0BF-17C5-4952-94E8-EDE99BFCE834Q35021696-F9A031E5-EB30-44C8-94CB-CF76C20C2A40Q35324234-872846C8-66C7-492A-AE94-86FD917173A4Q35636757-CE4E0A04-1922-4F58-B433-CC5D0F8BAFD6Q35979523-2FC62AFB-89E0-40FB-9C63-9D5C071582FCQ36188016-0C877ACB-166C-4A26-992B-1D97D3C36C06Q36236299-ABABD490-4E80-4AA2-832C-8D78B809FD4EQ36258802-F82409A2-F55F-43C5-AF8A-54C35AD4CA57Q36508873-B96CD942-A7C3-4233-AD1C-16324315AE17Q37262846-788AD280-9C4A-4512-8EBE-CCBE6F1D36AFQ37479391-BAFE854E-B392-4B73-917E-64F70B400D05Q37569392-F90B6A46-A940-4AC3-A409-0E0BD5F8206EQ38069632-4E64C3A7-1581-46A2-BC07-0E1AAA75E882Q38216228-30C4A467-4CD6-4D57-BB4A-632B84F7B020Q38440248-58F4607F-3E7A-4B04-9B95-A063994D9915Q38851232-5DF1DB49-84DA-40E6-8F11-11FD07CFFCC9Q38866136-973097B9-5171-4AB5-A06F-776F01314F98Q38979943-FFC837EC-A8B3-49B6-AA11-C60F83214094Q39024503-B6B8CAF2-142B-4EBA-9D6C-92909AE65D73Q39322673-76F60C78-EDF7-4722-9667-4A123D1DB750Q39528276-3BC69374-EF7E-49CB-BD62-049936D68FB4Q39804979-C78F6706-147B-4A4F-9660-D3BDF5555C94Q40086592-9CC2FDBE-A999-4452-88C4-95C6D6EC7296Q40173081-AE99A7EF-7746-49EE-A2A0-F756B5F32342Q40560295-E07C1E6D-FFBB-46C2-B499-7183E2874BC6Q40936792-CFC2D946-B6AA-4A70-8B7F-DBF1D98AF246Q40966248-F0F3AEC2-23BD-4A54-8EB3-29E30B89D98FQ41090275-049C4A65-7F6E-4722-978A-AD956FAB2ADFQ41344183-E28BA9B2-6ACE-40E4-9B15-5CAE85B4C503Q41501252-BEA10D4C-7439-41C0-A031-06D4DBAEC3BDQ41640329-648F84E1-8215-4E47-AFDC-2FD2BFD1AA32
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
N Girerd
@nl
N Girerd
@sl
Nicolas Girerd
@en
Nicolas Girerd
@es
type
label
N Girerd
@nl
N Girerd
@sl
Nicolas Girerd
@en
Nicolas Girerd
@es
altLabel
N Girerd
@en
N. Girerd
@en
prefLabel
N Girerd
@nl
N Girerd
@sl
Nicolas Girerd
@en
Nicolas Girerd
@es
P106
P21
P31
P496
0000-0002-3278-2057